18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 15 Feb 2017
At a glance
- Drugs F-18 fluorothymidine (Primary) ; Fluciclovine 18F (Primary)
- Indications CNS cancer; Glioma; Tumours
- Focus Diagnostic use
- 07 Jun 2017 Biomarkers information updated
- 15 Feb 2017 Last checked against ClinicalTrials.gov record.
- 15 Feb 2017 Planned End Date changed from 1 Jan 2017 to 1 Jan 2018.